Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-20

Clinical Trial Update: Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

This is a completed open-label Phase 1/2 trial evaluating the safety and effectiveness of DIABECELL in people with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIABECELL

Snippet

Sponsor: Diatranz Otsuka Limited | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED